Get the Stockscreener App
0.8102
8.14%
-0.0718
After Hours:
.82
0.0098
+1.21%
Adicet Bio Inc stock is traded at $0.8102, with a volume of 535.86K.
It is down -8.14% in the last 24 hours and up +26.79% over the past month.
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.
See More
Previous Close:
$0.882
Open:
$0.86
24h Volume:
535.86K
Relative Volume:
1.12
Market Cap:
$67.45M
Revenue:
$24.99M
Net Income/Loss:
$-118.64M
P/E Ratio:
-0.6185
EPS:
-1.31
Net Cash Flow:
$-100.25M
1W Performance:
+12.48%
1M Performance:
+26.79%
6M Performance:
+2.05%
1Y Performance:
-47.05%
1-Day Range:
$0.7768
$0.8863
1-Week Range:
$0.6901
$0.8968
52-Week Range:
$0.4471
$1.61
Adicet Bio Inc Stock (ACET) Company Profile
Name
Adicet Bio Inc
Sector
Industry
Phone
617-482-2333
Address
131 DARTMOUTH STREET, BOSTON
Compare ACET with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ACET
Adicet Bio Inc
|
0.8102 | 66.87M | 24.99M | -118.64M | -100.25M | -1.31 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Adicet Bio Inc Stock (ACET) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-30-24 | Resumed | Guggenheim | Buy |
| Sep-11-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jun-27-23 | Downgrade | Guggenheim | Buy → Neutral |
| Jun-27-23 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Jun-01-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-21-22 | Initiated | JP Morgan | Overweight |
| Mar-31-22 | Initiated | SMBC Nikko | Outperform |
| Mar-08-22 | Initiated | Truist | Buy |
| Mar-04-22 | Initiated | Jefferies | Buy |
| May-18-21 | Initiated | BTIG Research | Buy |
| Apr-23-21 | Initiated | H.C. Wainwright | Buy |
| Apr-14-21 | Initiated | Canaccord Genuity | Buy |
| Apr-08-21 | Initiated | Guggenheim | Buy |
| Nov-04-20 | Initiated | B. Riley Securities | Buy |
| Oct-27-20 | Initiated | JMP Securities | Mkt Outperform |
| Oct-16-20 | Initiated | Wedbush | Outperform |
View All
Adicet Bio Inc Stock (ACET) Latest News
Analyzing recovery setups for Adicet Bio Inc. investorsTrade Analysis Summary & Weekly High Return Stock Opportunities - Newser
Is Adicet Bio Inc. stock ready for a breakoutJuly 2025 Macro Moves & Reliable Volume Spike Trade Alerts - Newser
Candlestick signals on Adicet Bio Inc. stock todayWeekly Stock Recap & AI Driven Price Predictions - Newser
Is Adicet Bio Inc. stock poised for growthDip Buying & Stepwise Trade Signal Implementation - Newser
Is this a good reentry point in Adicet Bio Inc.Weekly Investment Summary & Low Risk Entry Point Guides - Newser
Will Adicet Bio Inc. stock go up soonWeekly Trend Recap & Expert Curated Trade Setup Alerts - Newser
Adicet Bio Inc. recovery potential after sell offPortfolio Gains Summary & Daily Chart Pattern Signals - Newser
Will Adicet Bio Inc. stock recover after recent dropFed Meeting & Smart Money Movement Alerts - Newser
Adicet Bio (NASDAQ:ACET) Shares Pass Above Two Hundred Day Moving AverageWhat's Next? - MarketBeat
Volatility clustering patterns for Adicet Bio Inc.Weekly Stock Recap & Weekly Return Optimization Alerts - Newser
What does recent volatility data suggest for Adicet Bio Inc.July 2025 Volume & Weekly Market Pulse Alerts - Newser
Statistical indicators supporting Adicet Bio Inc.’s strengthJuly 2025 Trade Ideas & Fast Exit and Entry Strategy Plans - Newser
Key resistance and support levels for Adicet Bio Inc.Portfolio Performance Report & AI Enhanced Trade Execution Alerts - Newser
Using data models to predict Adicet Bio Inc. stock movementPortfolio Return Report & Weekly High Momentum Picks - Newser
Backtesting results for Adicet Bio Inc. trading strategies2025 Earnings Impact & Community Verified Swing Trade Signals - Newser
What MACD and RSI say about Adicet Bio Inc.Portfolio Profit Report & Growth Oriented Trade Recommendations - Newser
How to manage a losing position in Adicet Bio Inc.Portfolio Growth Summary & Free Risk Controlled Daily Trade Plans - Newser
Reversal indicators forming on Adicet Bio Inc. stockWeekly Profit Summary & Consistent Income Trade Ideas - Newser
Short interest data insights for Adicet Bio Inc.July 2025 Reactions & Verified Swing Trading Watchlist - Newser
Signal strength of Adicet Bio Inc. stock in tech scannersJuly 2025 News Drivers & Fast Entry Momentum Alerts - Newser
Is Adicet Bio Inc. a candidate for recovery playMarket Performance Recap & Growth Focused Stock Pick Reports - Newser
Detecting price anomalies in Adicet Bio Inc. with AI2025 Institutional Moves & Free Weekly Chart Analysis and Trade Guides - Newser
Citizens JMP reiterates Market Perform rating on Adicet Bio stock By Investing.com - Investing.com Australia
Citizens JMP reiterates Market Perform rating on Adicet Bio stock - Investing.com
Published on: 2025-09-08 21:35:12 - beatles.ru
Tick level data insight on Adicet Bio Inc. volatilityPortfolio Performance Report & Verified Chart Pattern Signals - Newser
Is Adicet Bio Inc. stock a good dividend stockEarnings Miss & Smart Allocation Stock Tips - خودرو بانک
Is Adicet Bio Inc. forming a bullish divergenceJuly 2025 Intraday Action & Expert Curated Trade Setup Alerts - خودرو بانک
Adicet Bio (NASDAQ:ACET) Stock Passes Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat
Published on: 2025-09-05 22:57:41 - خودرو بانک
What is the next catalyst for Adicet Bio Inc.July 2025 Summary & Consistent Return Investment Signals - خودرو بانک
Is Adicet Bio Inc. affected by consumer sentimentMarket Growth Review & Free Growth Oriented Trading Recommendations - خودرو بانک
How hedge fund analytics apply to Adicet Bio Inc. stockJuly 2025 Analyst Calls & Precise Buy Zone Tips - Newser
Layoff Tracker: AC Immune To Cut 30% of Workforce - BioSpace
Published on: 2025-09-05 05:46:56 - Newser
What’s the analyst consensus on Adicet Bio Inc.2025 Growth vs Value & AI Powered Market Entry Ideas - خودرو بانک
Real time breakdown of Adicet Bio Inc. stock performanceJuly 2025 Intraday Action & AI Enhanced Market Trend Forecasts - Newser
Adicet Bio Inc. stock chart pattern explainedCEO Change & Fast Momentum Stock Entry Tips - Newser
Is now a turning point for Adicet Bio Inc.2025 Price Action Summary & Reliable Price Breakout Alerts - Newser
Is Adicet Bio Inc. showing signs of accumulationProfit Target & Consistent Profit Alerts - Newser
Trend analysis for Adicet Bio Inc. this weekJuly 2025 Review & Capital Protection Trading Alerts - Newser
Tools to assess Adicet Bio Inc.’s risk profileTrade Exit Summary & Stepwise Swing Trade Plans - Newser
Chart based exit strategy for Adicet Bio Inc.2025 Investor Takeaways & Reliable Volume Spike Alerts - Newser
Why Adicet Bio Inc. is moving todayMarket Trend Review & Weekly Momentum Stock Picks - Newser
Analyzing Adicet Bio Inc. with risk reward ratio chartsRate Hike & Fast Momentum Stock Entry Tips - Newser
Price action breakdown for Adicet Bio Inc.Weekly Loss Report & Fast Exit and Entry Trade Guides - Newser
Is now the right time to enter Adicet Bio Inc.2025 Growth vs Value & Daily Market Momentum Tracking - خودرو بانک
Adicet Bio Inc Stock (ACET) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):